CoChat
Sign Up
Cited by 90

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Extracellular Vesicles of Alzheimer’s Disease Patients as a Biomarker for Disease Progression

Aharon, Anat, Spector, Polina, Ahmad, Rawan Sayed, Horrany, Nizar, Sabbach, Annie, Brenner, Benjamin, Aharon-Peretz, Judith·2020·Molecular Neurobiology
DOI 10.1007/s12035-020-02013-1
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1007/s12035-020-02013-1

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Research works printed but not linked: 69

  1. Aggarwal NT, Shah RC, Bennett DA (2015) Alzheimer’s disease: unique markers for diagnosis & new treatment modalities. Indian J Med Res 142:369–382 · DOI
  2. Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505–508 · DOI
  3. Minter MR, Taylor JM, Crack PJ (2016) The contribution of neuroinflammation to amyloid toxicity in Alzheimer’s disease. J Neurochem 136:457–474 · DOI · Paper page
  4. Battistelli M, Falcieri E (2020) Apoptotic bodies: particular extracellular vesicles involved in intercellular communication. Biology 9 · DOI
  5. Fruhbeis C, Frohlich D, Kuo WP, Kramer-Albers EM (2013) Extracellular vesicles as mediators of neuron-glia communication. Front Cell Neurosci 7:182 · DOI
  6. Ambros V, Lee RC (2004) Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol 265:131–158
  7. Simak J, Gelderman MP (2006) Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20:1–26 · DOI
  8. Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D (2016) Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30:836–848 · DOI · Paper page
  9. Yang Y, Boza-Serrano A, Dunning CJR, Clausen BH, Lambertsen KL, Deierborg T (2018) Inflammation leads to distinct populations of extracellular vesicles from microglia. J Neuroinflammation 15:168 · DOI
  10. Yamamoto S, Niida S, Azuma E, Yanagibashi T, Muramatsu M, Huang TT, Sagara H, Higaki S et al (2015) Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci Rep 5:8505 · DOI
  11. Couch Y, Akbar N, Davis S, Fischer R, Dickens AM, Neuhaus AA, Burgess AI, Rothwell PM et al (2017) Inflammatory stroke extracellular vesicles induce macrophage activation. Stroke 48:2292–2296 · DOI
  12. Abels ER, Breakefield XO (2016) Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol 36:301–312 · DOI
  13. Budnik V, Ruiz-Canada C, Wendler F (2016) Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci 17:160–172 · DOI · Paper page
  14. Perez-Gonzalez R, Gauthier SA, Kumar A, Levy E (2012) The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J Biol Chem 287:43108–43115 · DOI
  15. Agliardi C, Clerici M (2020) Blood extracellular vesicles (EVs) of central nervous system origin: a window into the brain. Neural Regen Res 15:55–56 · DOI
  16. Bianco F, Pravettoni E, Colombo A, Schenk U, Moller T, Matteoli M, Verderio C (2005) Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol 174:7268–7277 · DOI · Paper page
  17. Schiera G, Di Liegro CM, Di Liegro I (2015) Extracellular membrane vesicles as vehicles for brain cell-to-cell interactions in physiological as well as pathological conditions. Biomed Res Int 2015:152926 · DOI · Paper page
  18. Croese T, Furlan R (2018) Extracellular vesicles in neurodegenerative diseases. Mol Asp Med 60:52–61 · DOI
  19. Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR (2015) Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS One 10:e0139233 · DOI · Paper page
  20. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K (2006) Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 103:11172–11177 · DOI · Paper page
  21. Yuyama K, Sun H, Usuki S, Sakai S, Hanamatsu H, Mioka T, Kimura N, Okada M et al (2015) A potential function for neuronal exosomes: sequestering intracerebral amyloid-beta peptide. FEBS Lett 589:84–88 · DOI
  22. Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology Chapter 3, Unit 3 22 · DOI · Paper page
  23. Ender F, Zamzow P, Bubnoff NV, Gieseler F (2019) Detection and quantification of extracellular vesicles via FACS: membrane labeling matters! Int J Mol Sci 21 · DOI
  24. Yuana Y, Boing AN, Grootemaat AE, van der Pol E, Hau CM, Cizmar P, Buhr E, Sturk A et al (2015) Handling and storage of human body fluids for analysis of extracellular vesicles. J Extracellular Vesicles 4:29260 · DOI
  25. Lorincz AM, Timar CI, Marosvari KA, Veres DS, Otrokocsi L, Kittel A, Ligeti E (2014) Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes. J Extracellular Vesicles 3:25465 · DOI
  26. Gardiner C, Ferreira YJ, Dragovic RA, Redman CW, Sargent IL (2013) Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracellular Vesicles 2 · DOI
  27. Hosseinzadeh S, Zahmatkesh M, Zarrindast MR, Hassanzadeh GR, Karimian M, Sarrafnejad A (2013) Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment. Behav Brain Res 256:503–511 · DOI
  28. Andreu Z, Yanez-Mo M (2014) Tetraspanins in extracellular vesicle formation and function. Front Immunol 5:442 · DOI
  29. Katzenell S, Shomer E, Zipori Y, Zylberfisz A, Brenner B, Aharon A (2012) Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications. Thromb Res 130:479–484 · DOI
  30. Ramanathan S, Dale RC, Brilot F (2016) Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev 15:307–324 · DOI
  31. Wang C, Yang B, Fang D, Zeng H, Chen X, Peng G, Cheng Q, Liang G (2018) The impact of SNAP25 on brain functional connectivity density and working memory in ADHD. Biol Psychol 138:35–40 · DOI
  32. Inaguma S, Wang Z, Lasota JP, Miettinen MM (2016) Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors. Oncotarget 7:55276–55289 · DOI
  33. Akiyama H, Nishimura T, Kondo H, Ikeda K, Hayashi Y, McGeer PL (1994) Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer’s disease and amyotrophic lateral sclerosis. Brain Res 639:171–174 · DOI
  34. Rodosthenous RS, Coull BA, Lu Q, Vokonas PS, Schwartz JD, Baccarelli AA (2016) Ambient particulate matter and microRNAs in extracellular vesicles: a pilot study of older individuals. Part Fibre Toxicol 13:13 · DOI
  35. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD, Prionidis K et al (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40:W498–W504 · DOI
  36. Lea J, Sharma R, Yang F, Zhu H, Ward ES, Schroit AJ (2017) Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study. Oncotarget 8:14395–14407 · DOI
  37. Colombo E, Borgiani B, Verderio C, Furlan R (2012) Microvesicles: novel biomarkers for neurological disorders. Front Physiol 3:63 · DOI
  38. Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G (2018) Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol 135:311–336 · DOI · Paper page
  39. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157–171 · DOI
  40. Peschl P, Bradl M, Hoftberger R, Berger T, Reindl M (2017) Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol 8:529 · DOI
  41. Zhan X, Jickling GC, Ander BP, Liu D, Stamova B, Cox C, Jin LW, DeCarli C et al (2014) Myelin injury and degraded myelin vesicles in Alzheimer’s disease. Curr Alzheimer Res 11:232–238 · DOI
  42. Caso F, Agosta F, Filippi M (2016) Insights into white matter damage in Alzheimer’s disease: from postmortem to in vivo diffusion tensor MRI studies. Neurodegener Dis 16:26–33 · DOI
  43. McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M et al (2017) Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol 134:459–473 · DOI
  44. Samatov TR, Wicklein D, Tonevitsky AG (2016) L1CAM: cell adhesion and more. Prog Histochem Cytochem 51:25–32 · DOI
  45. Rathjen FG, Schachner M (1984) Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. EMBO J 3:1–10 · DOI
  46. Xue S, Cai X, Li W, Zhang Z, Dong W, Hui G (2012) Elevated plasma endothelial microparticles in Alzheimer’s disease. Dement Geriatr Cogn Disord 34:174–180 · DOI
  47. Sagare AP, Bell RD, Zlokovic BV (2013) Neurovascular defects and faulty amyloid-beta vascular clearance in Alzheimer’s disease. J Alzheimer’s Dis 33(Suppl 1):S87–S100
  48. Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, Monsell SE, Kukull WA et al (2013) Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre. Brain J Neurol 136:2697–2706 · DOI · Paper page
  49. Aharon A, Tamari T, Brenner B (2008) Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost 100:878–885 · DOI
  50. Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB et al (2016) Plasma EGF and cognitive decline in Parkinson’s disease and Alzheimer’s disease. Ann Clin Transl Neurol 3:346–355 · DOI
  51. Guo H, Xia D, Liao S, Niu B, Tang J, Hu H, Qian H, Cao B (2019) Vascular endothelial growth factor improves the cognitive decline of Alzheimer’s disease via concurrently inducing the expression of ADAM10 and reducing the expression of beta-site APP cleaving enzyme 1 in Tg2576 mice. Neurosci Res 142:49–57 · DOI
  52. Asahina M, Yoshiyama Y, Hattori T (2001) Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer’s disease brain. Clin Neuropathol 20:60–63
  53. Kissel K, Berber S, Nockher A, Santoso S, Bein G, Hackstein H (2006) Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion 46:818–827 · DOI
  54. Wang WY, Tan MS, Yu JT, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann Transl Med 3:136
  55. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA (1996) IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157:3223–3227 · DOI
  56. Zhang C (2008) The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 103:398–406 · DOI
  57. Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M et al (2013) Circulating miRNA biomarkers for Alzheimer’s disease. PLoS One 8:e69807 · DOI
  58. Jia LH, Liu YN (2016) Downregulated serum miR-223 servers as biomarker in Alzheimer’s disease. Cell Biochem Funct 34:233–237 · DOI · Paper page
  59. Dong H, Li J, Huang L, Chen X, Li D, Wang T, Hu C, Xu J et al (2015) Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer’s disease. Dis Markers 2015:625659
  60. Krstic D, Knuesel I (2013) Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol 9:25–34 · DOI · Paper page
  61. Liu Y, Song X, Meng S, Jiang M (2016) Downregulated expression of miR-142-3p in macrophages contributes to increased IL-6 levels in aged mice. Mol Immunol 80:11–16 · DOI
  62. Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, Zhang J, Tun N et al (2018) Regulation of human natural killer cell IFN-gamma production by microRNA-146a via targeting the NF-kappaB signaling pathway. Front Immunol 9:293 · DOI
  63. Zhang N, Fu L, Bu Y, Yao Y, Wang Y (2017) Downregulated expression of miR-223 promotes toll-like receptor-activated inflammatory responses in macrophages by targeting RhoB. Mol Immunol 91:42–48 · DOI
  64. Wang YS, Hsi E, Cheng HY, Hsu SH, Liao YC, Juo SH (2017) Let-7g suppresses both canonical and non-canonical NF-kappaB pathways in macrophages leading to anti-atherosclerosis. Oncotarget 8:101026–101041 · DOI
  65. Absalon S, Kochanek DM, Raghavan V, Krichevsky AM (2013) MiR-26b, upregulated in Alzheimer’s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci 33:14645–14659 · DOI · Paper page
  66. Wattmo C, Wallin AK (2017) Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years. Alzheimers Res Ther 9:70 · DOI
  67. Maas SL, de Vrij J, van der Vlist EJ, Geragousian B, van Bloois L, Mastrobattista E, Schiffelers RM, Wauben MH et al (2015) Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J Control Release Off J Control Release Soc 200:87–96 · DOI
  68. Szatanek R, Baj-Krzyworzeka M, Zimoch J, Lekka M, Siedlar M, Baran J (2017) The methods of choice for extracellular vesicles (EVs) characterization. Int J Mol Sci 18 · DOI
  69. Malishkevich A, Marshall GA, Schultz AP, Sperling RA, Aharon-Peretz J, Gozes I (2016) Blood-borne activity-dependent neuroprotective protein (ADNP) is correlated with premorbid intelligence, clinical stage, and Alzheimer’s disease biomarkers. J Alzheimer's Dis 50:249–260 · DOI

Cited by

Sorted by citations

See all 90

Metadata

Authors
Aharon, A., Spector, P., Ahmad, R. S., Horrany, N., Sabbach, A., Brenner, B., & Aharon-Peretz, J.
ORCID
Aharon, Anat
Venue
Molecular Neurobiology
Publisher
Springer Science and Business Media LLC
Published
2020-07-17
Volume
57
Issue
10
Pages
4156-4169
ISSN
  • 0893-7648
  • 1559-1182
DOI
10.1007/s12035-020-02013-1
Cited by
90
References
8
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extracellular Vesicles of Alzheimer’s Disease Patients as a Biomarker for Disease Progression. https://app.cochat.ai/papers/10.1007/s12035-020-02013-1
The paper
Aharon, A., Spector, P., Ahmad, R. S., Horrany, N., Sabbach, A., Brenner, B., & Aharon-Peretz, J. (2020). Extracellular Vesicles of Alzheimer’s Disease Patients as a Biomarker for Disease Progression. Molecular Neurobiology. https://doi.org/10.1007/s12035-020-02013-1